Home > People > Speakers > Onno van de Stolpe
Newsletter
Keep informed with the Innovation for Health newsletter!


Keep updated! Submit

Meet our Speaker
Meet our Speakers!

Onno van de Stolpe, Galapagos More speakers

Innovation for Health 2018: save the date!

We are pleased to announce the fifth edition of Innovation for Health to be held in WTC Rotterdam on 1 February 2018. Registration is now open. Register before the 15th of September 2017, and benefit from the attractive early-bird rate! Register now!


Twitterfeed

Onno van de Stolpe

CEO & Founder, Galapagos
Onno van de Stolpe founded Galapagos in 1999 and has served as Chief Executive Officer and a member of the board of directors from 1999 to the present. From 1998 to 1999, he was the Managing Director of Genomics at IntroGene B.V. (later Crucell N.V., which was acquired by Johnson & Johnson Services, Inc. in 2011). Prior to joining IntroGene in 1998, he was Managing Director of Molecular Probes Europe B.V. He established this European headquarters after joining Molecular Probes, Inc. in the United States. Previously, he worked for The Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotechnology and medical device companies to locate in The Netherlands. Mr. Van de Stolpe started his career as Manager of Business Development at MOGEN International N.V. in Leiden. He received an MSc degree from Wageningen University. Mr. Van de Stolpe currently also serves as a member of the supervisory board of the Stichting Institute for Human Organ and Disease Model Technologies and has previously served as a member of the board of directors of DCPrime B.V.

Connect with Onno van de Stolpe
Your logo here?

Become a sponsor

Main partner
Become a sponsor
Platinum sponsor
Become a sponsor
Organised by
Become a sponsor
Silver sponsor
Become a sponsor
Award sponsor
Become a sponsor